Fingerprint Dive into the research topics of 'Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Bevacizumab for metastatic colorectal cancer: A global cost-effectiveness analysis
Daniel A. Goldstein, Qiushi Chen, Turgay Ayer, Kelvin K.W. Chan, Kiran Virik, Ariel Hammerman, Baruch Brenner, Christopher R. Flowers, Peter S. Hall
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations